[The clinical usefulness and efficacy of adenosine triphosphate in an emergency service].
We studied 89 patients diagnosed in our emergency department of paroxysmal supraventricular tachycardia, to describe the efficacy and safety of intravenous adenosine triphosphate (ATP) in their treatment. All received a first bolus of 10 mg of ATP and if no electrical response was observed, a second dose of 20 mg. This treatment was successful in 91% of the patients, lasting of 26.9 seconds to resolve the episode, and in the 53% of the patients with the first dose. In 9% of the patients ATP did not resolve the episode but allowed to diagnose it, which in five patients was atrial flutter, in 2 Wolff-Parkinson-White syndrome and in one atrial fibrillation. Adverse effects appeared in 25.6% of the cases, being in all transitory and banal. ATP is a very effective and safe drug for the treatment of patients with PSVT.
Roig García
J J
JJ
Unidad Funcional de Urgencias, Hospital Universitario Reina Sofía, Córdoba.
Jiménez Murillo
L M
LM
Clemente Millán
M J
MJ
González Barranco
J M
JM
Segura Saint-Gerons
J
J
Montero Pérez
F J
FJ
D000255:Adenosine Triphosphate / Q000008:administration & dosage* / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D004341:Drug Evaluation; D004562:Electrocardiography / Q000187:drug effects; D004630:Emergencies; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013030:Spain / Q000453:epidemiology; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy / Q000453:epidemiology; D013617:Tachycardia, Supraventricular / Q000188:drug therapy / Q000453:epidemiology
D000255:Adenosine Triphosphate
Utilidad y eficacia clínica del adenosín trifosfato en un servicio de Urgencias.